286 related articles for article (PubMed ID: 27117376)
1. Age, independent from ovarian reserve status, is the main prognostic factor in natural cycle in vitro fertilization.
González-Foruria I; Peñarrubia J; Borràs A; Manau D; Casals G; Peralta S; Creus M; Ferreri J; Vidal E; Carmona F; Balasch J; Fàbregues F
Fertil Steril; 2016 Aug; 106(2):342-347.e2. PubMed ID: 27117376
[TBL] [Abstract][Full Text] [Related]
2. Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation?
Kedem A; Tsur A; Haas J; Yerushalmi GM; Hourvitz A; Machtinger R; Orvieto R
Fertil Steril; 2014 Jun; 101(6):1624-8. PubMed ID: 24680364
[TBL] [Abstract][Full Text] [Related]
3. Low dosing of gonadotropins in in vitro fertilization cycles for women with poor ovarian reserve: systematic review and meta-analysis.
Youssef MA; van Wely M; Mochtar M; Fouda UM; Eldaly A; El Abidin EZ; Elhalwagy A; Mageed Abdallah AA; Zaki SS; Abdel Ghafar MS; Mohesen MN; van der Veen F
Fertil Steril; 2018 Feb; 109(2):289-301. PubMed ID: 29317127
[TBL] [Abstract][Full Text] [Related]
4. Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss in younger in vitro fertilization patients.
Bishop LA; Richter KS; Patounakis G; Andriani L; Moon K; Devine K
Fertil Steril; 2017 Dec; 108(6):980-987. PubMed ID: 29202975
[TBL] [Abstract][Full Text] [Related]
5. Is the type of gonadotropin-releasing hormone suppression protocol for ovarian hyperstimulation associated with ectopic pregnancy in fresh autologous cycles for in vitro fertilization?
Londra L; Moreau C; Strobino D; Bhasin A; Zhao Y
Fertil Steril; 2016 Sep; 106(3):666-72. PubMed ID: 27320035
[TBL] [Abstract][Full Text] [Related]
6. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.
Engmann L; DiLuigi A; Schmidt D; Nulsen J; Maier D; Benadiva C
Fertil Steril; 2008 Jan; 89(1):84-91. PubMed ID: 17462639
[TBL] [Abstract][Full Text] [Related]
7. Live-birth rates in very poor prognosis patients, who are defined as poor responders under the Bologna criteria, with nonelective single embryo, two-embryo, and three or more embryos transferred.
Gleicher N; Vega MV; Darmon SK; Weghofer A; Wu YG; Wang Q; Zhang L; Albertini DF; Barad DH; Kushnir VA
Fertil Steril; 2015 Dec; 104(6):1435-41. PubMed ID: 26348275
[TBL] [Abstract][Full Text] [Related]
8. Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study.
Schachter M; Friedler S; Ron-El R; Zimmerman AL; Strassburger D; Bern O; Raziel A
Fertil Steril; 2008 Oct; 90(4):1087-93. PubMed ID: 18023439
[TBL] [Abstract][Full Text] [Related]
9. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
Lainas TG; Sfontouris IA; Venetis CA; Lainas GT; Zorzovilis IZ; Tarlatzis BC; Kolibianakis EM
Hum Reprod; 2015 Oct; 30(10):2321-30. PubMed ID: 26307091
[TBL] [Abstract][Full Text] [Related]
10. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
[TBL] [Abstract][Full Text] [Related]
11. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
[TBL] [Abstract][Full Text] [Related]
12. BRCA mutation carriers show normal ovarian response in in vitro fertilization cycles.
Shapira M; Raanani H; Feldman B; Srebnik N; Dereck-Haim S; Manela D; Brenghausen M; Geva-Lerner L; Friedman E; Levi-Lahad E; Goldberg D; Perri T; Eldar-Geva T; Meirow D
Fertil Steril; 2015 Nov; 104(5):1162-7. PubMed ID: 26335130
[TBL] [Abstract][Full Text] [Related]
13. Does the time interval between hysteroscopic polypectomy and start of in vitro fertilization affect outcomes?
Pereira N; Amrane S; Estes JL; Lekovich JP; Elias RT; Chung PH; Rosenwaks Z
Fertil Steril; 2016 Feb; 105(2):539-44.e1. PubMed ID: 26604066
[TBL] [Abstract][Full Text] [Related]
14. Gonadotropin-releasing hormone analogue as sole luteal support in antagonist-based assisted reproductive technology cycles.
Bar Hava I; Blueshtein M; Ganer Herman H; Omer Y; Ben David G
Fertil Steril; 2017 Jan; 107(1):130-135.e1. PubMed ID: 28228316
[TBL] [Abstract][Full Text] [Related]
15. Higher rates of aneuploidy in blastocysts and higher risk of no embryo transfer in recurrent pregnancy loss patients with diminished ovarian reserve undergoing in vitro fertilization.
Shahine LK; Marshall L; Lamb JD; Hickok LR
Fertil Steril; 2016 Oct; 106(5):1124-1128. PubMed ID: 27371114
[TBL] [Abstract][Full Text] [Related]
16. Fertility outcome of laparoscopic treatment in patients with severe endometriosis and repeated in vitro fertilization failures.
Soriano D; Adler I; Bouaziz J; Zolti M; Eisenberg VH; Goldenberg M; Seidman DS; Elizur SE
Fertil Steril; 2016 Oct; 106(5):1264-1269. PubMed ID: 27343955
[TBL] [Abstract][Full Text] [Related]
17. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
[TBL] [Abstract][Full Text] [Related]
18. Diminished ovarian reserve is the predominant risk factor for gonadotropin-releasing hormone antagonist failure resulting in breakthrough luteinizing hormone surges in in vitro fertilization cycles.
Reichman DE; Zakarin L; Chao K; Meyer L; Davis OK; Rosenwaks Z
Fertil Steril; 2014 Jul; 102(1):99-102. PubMed ID: 24882557
[TBL] [Abstract][Full Text] [Related]
19. Risk of miscarriage in women with endometriosis: insights from in vitro fertilization cycles.
Leonardi M; Papaleo E; Reschini M; Pagliardini L; Benaglia L; Candotti G; Viganó P; Quaranta L; Munaretto M; Candiani M; Vercellini P; Somigliana E
Fertil Steril; 2016 Aug; 106(2):386-392.e3. PubMed ID: 27090864
[TBL] [Abstract][Full Text] [Related]
20. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM
Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
